Intravenous Immunoglobulin for Acute Intracranial Hemorrhage
NCT02782897
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Intracranial Hemorrhage, Hypertensive
Interventions
DRUG:
Immunoglobulin Therapy
OTHER:
Standard management
Sponsor
Wei Wang